Cite
HARVARD Citation
Conti, A. et al. (2019). Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. British journal of dermatology. pp. 1547-1548. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Conti, A. et al. (2019). Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. British journal of dermatology. pp. 1547-1548. [Online].